Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
9%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
18%
ALSO IN CANC
CANC
57
HOLDINGS
9%
ALSO IN PBE
SECTOR DRIFT (PBE minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 4.8% | 2.7% | 2.7% |
|
EXELIXIS INC | 2.7% | 3.0% | 2.7% |
|
HALOZYME THERAPEUTICS INC | 2.4% | 1.5% | 1.5% |
|
GILEAD SCIENCES INC | 4.6% | 1.1% | 1.1% |
|
REGENERON PHARMACEUTICALS | 4.8% | 1.0% | 1.0% |
PBE Overweight Relative to CANC
|
BIOGEN IDEC INC | 5.5% |
|
VERTEX PHARMACEUTICALS INC | 4.9% |
|
ILLUMINA INC | 4.8% |
|
INCYTE CORP | 4.8% |
|
ROYALTY PHARMA PLC CLASS A | 4.7% |
|
IONIS PHARMACEUTICALS, INC. | 4.2% |
|
UNITED THERAPEUTICS CORP | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.7% |
|
GILEAD SCIENCES INC | 3.5% |
|
PTC THERAPEUTICS INC | 3.4% |
PBE Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -7.7% |
 |
NOVARTIS AG | -4.6% |
|
ELI LILLY & CO | -4.6% |
 |
ASTRAZENECA PLC | -4.3% |
|
BRIDGEBIO PHARMA, INC. | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.0% |
|
MERCK & CO. INC. | -3.9% |
 |
GENMAB A/S SPONSORED ADR | -3.8% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |
|
NUVALENT, INC. CLASS A | -3.2% |